592 related articles for article (PubMed ID: 27809338)
1. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
4. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
Barletta JF; Sclar DA
Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
Barkun AN; Bardou M; Pham CQ; Martel M
Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
[TBL] [Abstract][Full Text] [Related]
9. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
10. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
[TBL] [Abstract][Full Text] [Related]
11. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
[TBL] [Abstract][Full Text] [Related]
13. Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.
Li X; Klompas M; Menchaca JT; Young JG
Infect Control Hosp Epidemiol; 2020 Feb; 41(2):187-193. PubMed ID: 31818336
[TBL] [Abstract][Full Text] [Related]
14. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
Wang Y; Ye Z; Ge L; Siemieniuk RAC; Wang X; Wang Y; Hou L; Ma Z; Agoritsas T; Vandvik PO; Perner A; Møller MH; Guyatt GH; Liu L
BMJ; 2020 Jan; 368():l6744. PubMed ID: 31907166
[TBL] [Abstract][Full Text] [Related]
18. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
[TBL] [Abstract][Full Text] [Related]
19. Stress ulcer prophylaxis in critically ill children: Protocol for a systematic review.
Jensen MM; Marker S; Do HQ; Perner A; Møller MH
Acta Anaesthesiol Scand; 2019 Aug; 63(7):966-972. PubMed ID: 30907441
[TBL] [Abstract][Full Text] [Related]
20. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]